The landscape of dementia diagnosis has progressed considerably with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-centered assessments that may detect Alzheimer's pathology years in advance of signs arise. Even though these technological advances signify extraordinary progress in understanding neurodegenerative disorders, they've not diminished https://johnf319kvh1.wikigdia.com/user